| --- | --- | |-------|---------------------------------------------------------------------------| | | | | | | | | N O V E M B E R 7 , 2 0 2 4 EARNINGS CONFERENCE CALL 3 rd QUARTER | | | | PUBLIC 3Q24 EARNINGS CONFERENCE CALL DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS CONFIDENTIAL PUBLIC 2 | This presentation may contain forward-looking statements. These statements are not historical facts and are based on the Company's current vision and estimates of the Company's management regarding future economic ...

Braskem S.A. (NYSE:BAK) Q3 2024 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Rosana Avolio - IR, Strategic Planning & Corporate Market Intelligence Director Roberto Bischoff - CEO Pedro Freitas - CFO Conference Call Participants Rodrigo Almeida - Santander Vicente Falanga - Bradesco BBI Tasso Vasconcellos - UBS Gabriel Barra - Citi Pedro Soares - BTG Pactual Leonardo Marcondes - Bank of America Regis Cardoso - XP, Inc. Operator Good morning and thank you for waiting. Welcome to ...

Highest quarterly Recurring EBITDA since 2Q22SÃO PAULO, Nov. 7, 2024 /PRNewswire/ --  BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK), the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 3Q24 Earnings Release.3Q24 HIGHLIGHTS CONSOLIDATED Recurring EBITDA of US$432 million, about 35% higher than in 2Q24 and 130% higher than in 3Q23. Cash position of US$2.4 billion, ensuring coverage of debt maturities over the next 52 months. Operating Cas ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2024 (Commission File No. 1-14862 ) BRASKEM S.A. (Exact Name as Specified in its Charter) N/A (Translation of registrant's name into English) Rua Eteno, 1561, Polo Petroquimico de Camacari Camacari, Bahia - CEP 42810-000 Brazil (Address of principal executive of ices) Indicate by check mark whether the registran ...

Joa_Souza Investment Thesis I recommend buying Braskem (NYSE:BAK) shares after the release of 2Q24 results, which, although below market expectations, showed good signs of operational improvement for the company. Although the company still has problems with financial expenses and net losses, Braskem achieved excellent cost control in 2Q24, which combined with a 33% appreciation potential makes me confident in the thesis. Review Of Braskem's 2Q24 Results Braskem released its 2nd quarter results on August 8th ...

Braskem (BAK) closed the last trading session at $6.38, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $9.33 indicates a 46.2% upside potential.The average comprises three short-term price targets ranging from a low of $8 to a high of $10, with a standard deviation of $1.15. While the lowest estimate indicates an increase of 25.4% from the current price level, the most ...

EARNINGS CONFERENCE CALL 2 nd QUARTER 2024 A U G U S T 8 , 2 0 2 4 Braskem Industrial area (PE6) Triunfo, Rio Grande do Sul 2Q24 EARNINGS CONFERENCE CALL DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS CONFIDENTIAL PUBLIC 2 | This presentation may contain forward-looking statements. These statements are not historical facts and are based on the Company's current vision and estimates of the Company's management regarding future economic and other circumstances, industry conditions, performance and financial ...

Financial Data and Key Metrics Changes - In Q2 2024, Braskem's recurring EBITDA was $320 million, a 39% increase from the previous quarter and a 128% increase year-over-year [8][18] - Operating cash generation increased by 9% compared to the last quarter, reaching $214 million, while recurring cash generation was positive at $69 million [8] - The company maintained a liquidity position of $2.8 billion at the end of the quarter, with a leverage ratio of 6.8 times, down from the previous quarter [9][20] Business Line Data and Key Metrics Changes - In Brazil, the recurring EBITDA was $231 million, a 10% increase from the previous quarter, positively impacted by better spreads and cost reductions [14] - The United States and Europe segment saw a recurring EBITDA of $46 million, a 33% decrease from the first quarter, due to lower production and sales [16] - In Mexico, the recurring EBITDA was $56 million, a 53% increase from the first quarter, driven by higher sales volume and improved spreads [17] Market Data and Key Metrics Changes - The petrochemical spreads improved in the international market due to better supply-demand balance and increased maritime freight rates [7][18] - The utilization rate in Brazil decreased by 3 percentage points due to extreme weather, while the U.S. and Europe segment's utilization rate increased by 2 percentage points [11][16] - The Mexican segment's utilization rate was 78%, down 5 percentage points from the last quarter, impacted by lower ethane supply [17] Company Strategy and Development Direction - Braskem is advancing its corporate strategy towards 2030, with significant progress in the construction of an ethane import terminal in Mexico, expected to be operational by Q1 2025 [11][30] - The company is focusing on decarbonization initiatives, including partnerships for energy efficiency and the development of renewable energy projects [12][28] - A strategic partnership with Solvà and GRI aims to create a national platform for environmental solutions, resulting in a positive impact of R$284 million for Braskem [12][30] Management's Comments on Operating Environment and Future Outlook - Management expects improved usage rates in Brazil and increased sales volume in Q3 2024, driven by better product availability and demand [25] - The company anticipates a gradual balance in global petrochemical spreads, influenced by ongoing logistical restrictions [27] - Management highlighted the importance of government support for long-term restructuring and competitiveness in the Brazilian petrochemical industry [67] Other Important Information - Braskem's debt profile remains long-term, with 64% of debt maturing after 2030, and the company is committed to maintaining liquidity and reducing leverage [9][20] - The company reported a total provision of R$15.9 billion related to the Alagoas event, with significant disbursements already made [25] Q&A Session Summary Question: Demand outlook for Brazil in Q3 - Management forecasts a polymer demand growth of 13% in Brazil, with sales recovering at a slower rate of 2% to 3% [35] Question: Impact of container prices and butadiene prices - Increased freight rates due to conflicts in the Red Sea have affected resin prices, while butadiene prices have risen nearly 50% due to lower global supply [42][44] Question: Working capital and CapEx dynamics - CapEx is expected to be around $400 million for the year, with no significant changes in working capital anticipated [48][49] Question: Global supply and demand dynamics - New capacity is expected in polyethylene, while polypropylene capacity is increasing, particularly in China [55] Question: Cash generation outlook - The company anticipates neutral cash generation for 2024, excluding the Alagoas event, with a positive outlook for 2025 [68]

SÃO PAULO, Aug. 8, 2024 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 2Q24 Earnings Release.2Q24 HIGHLIGHTS CONSOLIDATEDRecurring EBITDA of US$320 million, around R$1,667million, higher than 1Q24 (+39%) and 2Q23 (+128%).Cash position of US$2.8 billion, ensuring coverage of debt maturities over the next 5 years.Operating Cash Generation¹ of US$69 million, around R$357 mi ...

Joa_Souza Investment Thesis I recommend buying Braskem (NYSE:BAK) shares. Braskem's controlling company, Novonor, is in judicial recovery and has Braskem as its most valuable asset. Therefore, Novonor is looking for a buyer for its stake in Braskem. The most interesting thing is that Braskem is extremely cheap when we analyze its EV/EBITDA compared to its peers, and the company has already received numerous purchase proposals that place its valuation at double the current market cap. Introduction The pe ...